Please check your internet connection and try again.
## Clotrimazole Drop
### Overview
Clotrimazole is a synthetic broad-spectrum antifungal agent used topically and orally. It inhibits the synthesis of ergosterol, a vital component of fungal cell membranes.
### Primary Indications
* **Otic:** Treatment of otomycosis (fungal infections of the ear canal), often caused by *Aspergillus* or *Candida* species.
* **Oral:** Treatment of oropharyngeal candidiasis (thrush).
### Adult Dosing
* **Otic:** Apply 3-4 drops into the affected ear(s) 2-3 times daily. Duration of treatment varies but is generally 1-2 weeks.
* **Oral:** **Troches:** Dissolve one 10 mg troche in the mouth slowly 5 times daily for 10-14 days. **Solution:** Apply 10 mg (1 mL) to the affected areas of the mouth 4 times daily for 7-14 days.
### Pediatric Dosing
* **Otic:** Not established for otic use in children.
* **Oral (Oropharyngeal Candidiasis):**
* **Troches:** Not recommended for children under 3 years of age due to risk of choking. For children 3 years and older, use the adult dose (10 mg troche dissolved slowly 5 times daily for 10-14 days).
* **Solution:** Age-specific dosing is not definitively established for the oral solution in neonates and infants. A common pediatric approach for infants and children involves applying 10 mg (1 mL) to affected oral areas 4 times daily. *Local protocol may dictate specific dosing for this age group.*
### Dose Adjustments
No dose adjustments are generally required for hepatic or renal impairment due to minimal systemic absorption with topical application.
### Contraindications
* Hypersensitivity to clotrimazole or any component of the formulation.
* Oral troches are contraindicated in children under 3 years of age.
### Adverse Effects
* **Otic:** Local irritation, burning, itching, stinging.
* **Oral:** Oral irritation, abnormal taste, nausea, vomiting, rash, angioedema (rare).
### Key Drug Interactions
Clotrimazole may increase the concentration of systemically absorbed drugs metabolized by cytochrome P450 enzymes (e.g., some immunosuppressants like tacrolimus, cyclosporine).
### Monitoring
* Monitor for resolution of fungal infection symptoms.
* Assess for local adverse reactions.
* For oral troches, monitor for signs of systemic drug interactions if the patient is on other medications metabolized by CYP enzymes.
### Clinical Pearls
* For otic use, ensure the ear canal is clean and dry before application.
* For oral troches, educate patients to dissolve the troche slowly in the mouth and not to chew or swallow it whole.
* For oral solution, instruct patients to apply directly to the affected areas.
* Treatment duration should be completed as prescribed, even if symptoms improve earlier, to prevent recurrence.
***
*This information is intended for healthcare professionals. Always consult current prescribing information and patient-specific factors before making clinical decisions.*
